2001•ACP Journal ClubRequires access

Review: Low-molecular-weight heparin may be as effective and safe as vitamin-K antagonists in symptomatic venous thromboembolism

John T. Philbrick

Open publisher page 0 citations

Abstract

Source Citation van der Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2000;(4):CD002001 (latest version 28 Mar 2000). 11034739

About this research paper

What this paper is about

Source Citation van der Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2000;(4):CD002001 (latest version 28 Mar 2000). 11034739

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Source Citation van der Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2000;(4):CD002001 (latest version 28 Mar 2000). 11034739

Key concepts: Medicine, Venous thromboembolism, Vitamin k, Low molecular weight heparin, Heparin, Internal medicine, Gastroenterology, Thrombosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Review: Low-molecular-weight heparin may be as effective and safe as vitamin-K antagonists in symptomatic venous thromboembolism — Research Paper | ScholarLens